학술논문

Exploiting frequent and specific expression of PRL3 in pediatric solid tumors for first-in-child use of PRL3-zumab humanized antibody
Document Type
Article
Source
In: Molecular Therapy Oncolytics. (Molecular Therapy Oncolytics, 21 September 2023, 30:153-166)
Subject
Language
English
ISSN
23727705